Latest news
Arthritis and musculoskeletal conditions affect 7 million Australians
Arthritis and musculoskeletal conditions affect almost 1 in 3 Australians 7 million voices | 7 million stories One in three, which is more than 7 million Australians of all ages, are living with arthritis and musculoskeletal (MSK) conditions. The next federal election could be called at any time, and we need our arthritis and MSK…
World Arthritis Day | 2024
World Arthritis Day 2024: Empowering Through Information October 12th marks World Arthritis Day, a global initiative to recognise the challenges faced by millions living with arthritis and musculoskeletal conditions. This year’s theme, “Informed Choices, Better Outcomes,” highlights the critical role of evidence-based information in empowering individuals to manage their health effectively. Click here to download…
Over 20 peak groups join Arthritis Australia’s call for urgent action on arthritis and musculoskeletal conditions.
Arthritis Australia and over 40 leading health stakeholders including over 20 peak bodies have issued a formal communique calling for urgent action to provide more affordable evidence based care, following the first national parliamentary summit on arthritis and musculoskeletal conditions, which recently brought together over 90 consumers, clinicians, researchers, policymakers and industry representatives. “Implementing proven…
Arthritis Australia’s first interactive Parliamentary Summit on Better Care for Arthritis and Musculoskeletal Conditions
Arthritis Australia’s first interactive Parliamentary Summit on Better Care for Arthritis and Musculoskeletal Conditions on 22 August was attended by over 90 consumers, clinicians, researchers, industry, peak groups, parliamentarians and policymakers who gathered to address the pressing challenge of arthritis and musculoskeletal conditions. With escalating health system and out of pocket costs, it’s crucial that…
ARTHRITIS AT BREAKING POINT: Greater access to physios, dietitians, and other allied health essential to stem staggering rise in hip and knee replacements
Arthritis Australia is calling for urgent, affordable access to lifestyle behavioural care from physiotherapists, dietitians, and other multidisciplinary allied health, to help address the escalating crisis in arthritis and musculoskeletal conditions now placing unprecedented strain on communities, hospitals and health budgets. The Australian Government’s Commission on Safety and Quality in Healthcare last week set a…
Parliamentary summit on better care for arthritis and musculoskeletal conditions
Click here to download the summit agenda Click here to download the communique Musculoskeletal conditions, including arthritis and back pain , affect around 7 million people or 1 in 3 Australians, and are a leading cause of chronic pain. As our most expensive disease group, they cost the health system almost $15 billion dollars a…
Arthritis Australia welcomes funding for kids with arthritis
Arthritis Australia has welcomed Australian Government funding announced in the federal budget for kids living with juvenile arthritis, including renewed funding for Arthritis Australia and its affiliates to expand access to juvenile arthritis kids camps. “Our kids camps play a vital role in supporting children with juvenile arthritis and their families to navigate this misunderstood…
Shortage of Abatacept (Orencia®) Resolved – update
Update: August 28, 2024. Bristol Myers Squibb (BMS), the manufacturer of Orencia (abatacept), has announced that the shortage of subcutaneous abatacept will be resolved as of the 30 August 2024. Starting from 30 August 2024: The TGA medicine shortage notification for abatacept 125 mg single dose syringe will no longer be in place. The abatacept…
Anticipated Shortage of Abatacept (Orencia®)
Bristol Myers Squibb (BMS), the manufacturer of abatacept (Orencia®), has recently announced an expected shortage of both the ClickJect (autoinjector) and pre-filled syringe subcutaneous formulations of the medication. According to BMS, a disruption in the supply chain is anticipated from June 2024, leading to the unavailability of abatacept for a period expected to be several…
Arthritis Australia, Chronic Pain Australia and Consumers Health Forum of Australia Joint Statement ABC 4 Corners “Pain Factory” episode
Tuesday 9 April 2024 Last night’s episode of ABC 4 Corners highlighted the many adverse events people living with chronic musculoskeletal pain have experienced when undergoing spinal fusion and spinal cord stimulator surgery to manage their pain. Arthritis Australia, Chronic Pain Australia and the Consumers Health Forum of Australia want to recognise the consumers, living…
Sign up to Arthritis Insights
Regular updates, news and research findings delivered to your inbox:
